Elliott Russell P. 4
4 · Foamix Pharmaceuticals Ltd. · Filed Apr 4, 2018
Insider Transaction Report
Form 4
Elliott Russell P.
VP Drug Development
Transactions
- Sale
Ordinary Shares
2018-04-02$5.08/sh−142$721→ 12,726 total
Footnotes (1)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of re-stricted share units. This sale is mandated by the Issuer's non-discretionary policy that requires the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.